URNEVA- methenamine, sodium phosphate, monobasic, monohydrate, phenyl salicylate, methylene blue, hyoscyamine sulfate capsule United States - English - NLM (National Library of Medicine)

urneva- methenamine, sodium phosphate, monobasic, monohydrate, phenyl salicylate, methylene blue, hyoscyamine sulfate capsule

scite pharma, llc - methenamine (unii: j50oix95qv) (methenamine - unii:j50oix95qv), sodium phosphate, monobasic, monohydrate (unii: 593yog76rn) (phosphate ion - unii:nk08v8k8hr, sodium cation - unii:lyr4m0nh37), phenyl salicylate (unii: 28a37t47qo) (phenyl salicylate - unii:28a37t47qo), methylene blue (unii: t42p99266k) (methylene blue cation - unii:zmz79891zh), hyoscyamine sulfate (unii: f2r8v82b84) (hyoscyamine - unii:px44xo846x) - urneva capsules is indicated for the treatment of symptoms of irritative voiding. indicated for the relief of local symptoms, such as inflammation, hypermotility, and pain, which accompany lower urinary tract infections. indicated for the relief of urinary tract symptoms caused by diagnostic procedures. urneva capsules is contraindicated in patients with a hypersensitivity to any of the ingredients. risk-benefit should be considered when the following medical problems exist: cardiac disease (especially cardiac arrhythmias, congestive heart failure, coronary heart disease, and mitral stenosis); gastrointestinal tract obstructive disease; glaucoma; myasthenia gravis; acute urinary retention may be precipitated in obstructive uropathy (such as bladder neck obstruction due to prostatic hypertrophy). a dependence on the use of urneva capsules has not been reported and due to the nature of its ingredients, abuse of urneva capsules is not expected.

URIMAR-T CAPS- methenamine, sodium phosphate, monobasic, monohydrate, phenyl salicylate, methylene blue, and hyoscyamine sulfate United States - English - NLM (National Library of Medicine)

urimar-t caps- methenamine, sodium phosphate, monobasic, monohydrate, phenyl salicylate, methylene blue, and hyoscyamine sulfate

allegis pharmaceuticals, llc - methenamine (unii: j50oix95qv) (methenamine - unii:j50oix95qv), sodium phosphate, monobasic, monohydrate (unii: 593yog76rn) (phosphate ion - unii:nk08v8k8hr, sodium cation - unii:lyr4m0nh37), phenyl salicylate (unii: 28a37t47qo) (phenyl salicylate - unii:28a37t47qo), methylene blue (unii: t42p99266k) (methylene blue cation - unii:zmz79891zh), hyoscyamine sulfate (unii: f2r8v82b84) (hyoscyamine - unii:px44xo846x) - urimar-t™ caps is indicated for the treatment of symptoms of irritative voiding. indicated for the relief of local symptoms, such as inflammation, hypermotility, and pain, which accompany lower urinary tract infections. indicated for the relief of urinary tract symptoms caused by diagnostic procedures. urimar-t™ caps is contraindicated in patients with a hypersensitivity to any of the ingredients. risk-benefit should be considered when the following medical problems exist: cardiac disease (especially cardiac arrhythmias, congestive heart failure, coronary heart disease, and mitral stenosis); gastrointestinal tract obstructive disease; glaucoma; myasthenia gravis; acute urinary retention may be precipitated in obstructive uropathy (such as bladder neck obstruction due to prostatic hypertrophy). a dependence on the use of urimar-t™ caps has not been reported and due to the nature of its ingredients, abuse of urimar t™ caps is not expected.

URIBEL TABS- methenamine, benzoic acid, phenyl salicylate, methylene blue, and hyoscyamine sulfate tablet, coated United States - English - NLM (National Library of Medicine)

uribel tabs- methenamine, benzoic acid, phenyl salicylate, methylene blue, and hyoscyamine sulfate tablet, coated

mission pharmacal company - hyoscyamine sulfate (unii: f2r8v82b84) (hyoscyamine - unii:px44xo846x), phenyl salicylate (unii: 28a37t47qo) (phenyl salicylate - unii:28a37t47qo), methenamine (unii: j50oix95qv) (methenamine - unii:j50oix95qv), methylene blue (unii: t42p99266k) (methylene blue cation - unii:zmz79891zh), benzoic acid (unii: 8skn0b0mim) (benzoic acid - unii:8skn0b0mim) - uribel tabs are indicated for the treatment of symptoms of irritative voiding. indicated for the relief of local symptoms, such as inflammation, hypermotility, and pain, which accompany lower urinary tract infections. indicated for the relief of urinary tract symptoms caused by diagnostic procedures. a dependence on the use of uribel tabs has not been reported and due to the nature of its ingredients, abuse of uribel tabs is not expected.

OPULETS PHYSOSTIGMINE EYE Ireland - English - HPRA (Health Products Regulatory Authority)

opulets physostigmine eye

alcon laboratories (uk) ltd - physostigmine -

ANTILIRIUM INJ 1MG/ML LIQUID Canada - English - Health Canada

antilirium inj 1mg/ml liquid

forest pharmaceuticals inc. - physostigmine salicylate - liquid - 1mg - physostigmine salicylate 1mg - parasympathomemetic (cholinergic) agents

URAMIT MB methenamine sodium phosphate monobasic monohydrate phenyl salicylate methylene blue and hyoscyamine sulfate capsule United States - English - NLM (National Library of Medicine)

uramit mb methenamine sodium phosphate monobasic monohydrate phenyl salicylate methylene blue and hyoscyamine sulfate capsule

burel pharmaceuticals, inc - methenamine (unii: j50oix95qv) (methenamine - unii:j50oix95qv) - methenamine 118 mg

HYOLEV MB hyoscyamine sulfate methenamine methylene blue phenyl salicylate and sodium phosphate monobasic monohydrate tablet United States - English - NLM (National Library of Medicine)

hyolev mb hyoscyamine sulfate methenamine methylene blue phenyl salicylate and sodium phosphate monobasic monohydrate tablet

burel pharmaceuticals, inc - hyoscyamine sulfate (unii: f2r8v82b84) (hyoscyamine - unii:px44xo846x) - hyoscyamine sulfate 0.12 mg

UROPHEN MB hyoscyamine sulfate methenamine methylene blue phenyl salicylate and benzoic acid tablet United States - English - NLM (National Library of Medicine)

urophen mb hyoscyamine sulfate methenamine methylene blue phenyl salicylate and benzoic acid tablet

burel pharmaceuticals, inc - hyoscyamine sulfate (unii: f2r8v82b84) (hyoscyamine - unii:px44xo846x) - hyoscyamine sulfate 0.12 mg

AZUPHEN MB hyoscyamine sulfate methenamine methylene blue phenyl salicylate and sodium phosphate monobasic monohydrate capsule United States - English - NLM (National Library of Medicine)

azuphen mb hyoscyamine sulfate methenamine methylene blue phenyl salicylate and sodium phosphate monobasic monohydrate capsule

burel pharmaceuticals, inc - hyoscyamine sulfate (unii: f2r8v82b84) (hyoscyamine - unii:px44xo846x) - hyoscyamine sulfate 0.12 mg

UR N-C URINARY ANTISEPTIC hyoscyamine sulfate methenamine phenyl salicylate sodium phosphate monobasic methylene blue tablet United States - English - NLM (National Library of Medicine)

ur n-c urinary antiseptic hyoscyamine sulfate methenamine phenyl salicylate sodium phosphate monobasic methylene blue tablet

mayne pharma inc. - hyoscyamine sulfate (unii: f2r8v82b84) (hyoscyamine - unii:px44xo846x) - hyoscyamine sulfate 0.12 mg